Get started
Author

Oriol Pedrós-Gámez

ORCID: 0000-0002-6050-9322
Observed ORCID: 0000-0002-6050-9322
OpenAlex ID: A5006595908
Endocytosis: A Turnover Mechanism Controlling Ion Channel Function
2020 · Irene Estadella, Oriol Pedrós-Gámez, et al. · Cells · 42
PDF
KCNE4-dependent functional consequences of Kv1.3-related leukocyte physiology
2021 · Albert Vallejo-Gracia, Daniel Sastre, et al. · Scientific Reports · 16
PDF
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer
2024 · Alexandra Leary, Purificación Estévez-García, et al. · BMC Cancer · 14
ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer
2025 · Joaquim Bosch-Barrera, Purificación Estévez-García, et al. · Lung Cancer · 11
Correction: ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer
2024 · Alexandra Leary, Purificación Estévez-García, et al. · BMC Cancer · 2
PDF
Phase 2 clinical trial of the proautophagic drug ABTL0812 combined with paclitaxel and carboplatin in first-line patients with advanced squamous non-small cell lung carcinoma.
2023 · Joaquim Bosch-Barrera, Teresa Moran, et al. · Journal of Clinical Oncology · 2
PDF
Phase IIb randomized trial of FOLFIRINOX plus ibrilatazar (ABTL0812) versus placebo as first-line treatment in metastatic pancreatic cancer: An analysis from the PanC-ASAP study.
2026 · Davendra Sohal, Anup Kasi, et al. · Journal of Clinical Oncology
The ER stress inducer ABTL0812/ibrilatazar potentiates standard chemotherapies and mitigates the immunosuppressive microenvironment in preclinical models of pancreatic cancer
2026 · Lorena Usero, Guillermo Yoldi, et al. · SSRN Electronic Journal
Works count: 8
Citation count: 87
H-index: 4
I10-index: 4
Year
Topic
Type